IL-1α, IL-1β, and IFN-γ Mark Β Cells for Fas-Dependent Destruction by Diabetogenic CD4+ T Lymphocytes
Journal of Clinical Investigation- United States
doi 10.1172/jci8185
Full Text
Abstract
Available in
Categories
Date
February 15, 2000
Authors
Publisher
American Society for Clinical Investigation